Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Board Change

16 Apr 2019 07:00

RNS Number : 2500W
Highlands Natural Resources PLC
16 April 2019
Β 

Β 

Β 

16 April 2019

Β 

Highlands Natural Resources plc ('Highlands' or 'the Company')

Board Change

Β 

Highlands, the London-listed natural resources company, is pleased to announce that Nick Tulloch has been appointed to the Board as Finance Director and Company Secretary.

Nick is expected to join the Company in the second quarter of 2019, following his release from his current employment. The date will be confirmed in due course. Melvyn Davies, the current Finance Director who helped establish the Company and has served as Director since its formation, will step down concurrently and will be available for a short period thereafter to effect a smooth transition.Β 

Nick is an experienced corporate finance adviser, having worked with companies listed on the London Stock Exchange for over 20 years. He is currently a Managing Director at Cantor Fitzgerald Europe's corporate finance department and has previously held senior positions at several other investment banks and stockbrokers. Nick is based in the UK and, in addition to his duties as Finance Director and Company Secretary, will also support the development of the Company's investor relations strategy.

Robert Price, the Company's Chairman and CEO, said: "Nick has been Highlands' financial adviser for the past four years and therefore already has a very strong working relationship with the team and our strategy. I am delighted to announce his appointment to the Board in the role of Finance Director.Β He joins Highlands at a pivotal time in our development as we seek to establish ourselves as organic CBD producers in Colorado, USA and I am confident that he will make a significant contribution. I would also like to thank Melvyn Davies for his hard work and invaluable advice since our IPO and wish him all the best for the future."

Listing Rule 9.6.13 disclosures

Highlands confirms that there are no disclosures to be made in respect of Nick for the purposes of Listing Rule 9.6.13.

***ENDS***

Β 

Β 

For further information:

Β 

Highlands Natural Resources plc

Robert Price +1 (0) 303 322 1066

Newgate Communications

Elisabeth Cowell

Fiona Norman +44 (0) 20 3757 6880

Β 

Notes to Editors

Highlands (LSE: HNR.L) is a London-listed natural resources company with a portfolio of high-potential assets and technologies. The Company's core projects include:

Β· Colorado Shale: Highlands holds a 7.5% carried interest in the East Denver Niobrara shale project. East Denver is currently producing from eight wells, with the potential for up to 24 wells in total. At its West Denver project, Highlands holds c. 5,300-acres of leases geologically similar to the East Denver project. This division also includes its patented anti well-bashing technology, DT Ultravert, successfully deployed in the Permian basin in 2018 and Piceance basinΒ in 2016.

Β· Kansas Gas Resource: 3,457-acres with the first well producing hydrogen-nitrogen with an initial flow rate of 2,581 Mcfpd. Potential for an additional 24 wells.

Β· Highlands Water Resources: formed to facilitate a range of initiatives focused on easing the water shortage currently being experienced across the US oil and gas industry, and particularly across more arid States such as Colorado. Utilises the E10X modular solar powered water-recycling units. Highlands is also exploring the potential to supply water from its 154,072 acreage in Montana.

Β· Zoetic Organics: newly formed subsidiary targeting the production of premium organic CBD products into wholesale and retail channels from a 33,000 sq. ft. indoor facility (potential annual harvest of 40,000 hemp plants) and an initial 20-acre outdoor growing facility (potential annual harvest of 50,000 hemp plants).

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOACKPDKPBKDNQD
Date   Source Headline
25th Jun 20204:00 pmRNSHolding(s) in Company
24th Jun 20203:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSSubscription for Equity
1st Jun 20207:00 amRNSNew Distribution Agreement and Trading Update
29th May 20207:00 amRNSFiling of Patents
27th May 20207:00 amRNSSale of DTU Interest and Kansas Nitrogen Assets
15th May 20207:00 amRNSTrading Update
11th May 20203:36 pmRNSHolding(s) in Company
6th May 20202:34 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSBoard and Strategy Changes, and Trading Update
3rd Apr 20207:00 amRNSIssue of Equity
1st Apr 20207:00 amRNSCOVID-19 Update
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSIssue of Equity
20th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20207:00 amRNSOperational update
12th Feb 20207:00 amRNSSubscription to raise £0.39 million
5th Feb 20207:00 amRNSTrading Update
23rd Dec 20197:00 amRNSInterim Results
16th Dec 20197:00 amRNSSettlement of Diversion Debt & Notice of Results
28th Nov 20197:00 amRNSResult of General Meeting
25th Nov 20197:00 amRNSTrading Update
14th Nov 20199:19 amRNSIssue of Equity
13th Nov 20192:06 pmRNSSecond Price Monitoring Extn
13th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSListing on the OTC
8th Nov 20199:01 amRNSIssue of Equity
7th Nov 20197:00 amRNSNotice of General Meeting
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
29th Oct 20194:42 pmRNSSecond Price Monitoring Extn
29th Oct 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20197:00 amRNSIssue of Shares
18th Oct 201911:05 amRNSSecond Price Monitoring Extn
18th Oct 201911:00 amRNSPrice Monitoring Extension
8th Oct 20197:00 amRNSAdoption of new share option scheme
4th Oct 20197:00 amRNSTrading Update
17th Sep 20197:00 amRNSDirectorate Change
12th Sep 201912:30 pmRNSDirector/PDMR Shareholding
9th Sep 201911:15 amRNSChange of Name
6th Sep 201910:30 amRNSDirector/PDMR Shareholding
4th Sep 201911:05 amRNSSecond Price Monitoring Extn
4th Sep 201911:00 amRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSDirectorate Change
30th Aug 20194:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.